4.5 Review

Growth factor delivery for tissue engineering

Journal

PHARMACEUTICAL RESEARCH
Volume 17, Issue 5, Pages 497-504

Publisher

SPRINGER/PLENUM PUBLISHERS
DOI: 10.1023/A:1007502828372

Keywords

tissue engineering; growth factors; controlled release; bone; nerve; liver

Funding

  1. NHLBI NIH HHS [R37-HL18672] Funding Source: Medline
  2. NIAMS NIH HHS [R29-AR42539] Funding Source: Medline
  3. NINDS NIH HHS [P01-NS23326] Funding Source: Medline

Ask authors/readers for more resources

A tissue-engineered implant is a biologic-biomaterial combination in which some component of tissue has been combined with a biomaterial to create a device for the restoration or modification of tissue or organ function. Specific growth factors, released from a delivery device or from co-transplanted cells. would aid in the induction of host paraenchymal cell infiltration and improve engraftment of co-delivered cells for more efficient tissue regeneration or ameliorate disease states. The characteristic properties of growth factors are described to provide a biological basis for their use in tissue engineered devices. The principles of polymeric device development for therapeutic growth factor delivery in the context of tissue engineering are outlined. A review of experimental evidence illustrates examples of growth factor delivery from devices such as micropaticles. scaffolds, and encapsulated cells, for their use in the application areas of musculoskeletal tissue, neural tissue, and hepatic tissue.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available